- Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients
Xin Zhao et al, 2014, Tumor Biology CrossRef - The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient
R. Mlak et al, 2016, Clinical and Translational Oncology CrossRef - Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients
Tomasz Powrózek et al, 2014, Clinical Lung Cancer CrossRef - Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness
Qingxiang Lin et al, 2024, Drug Resistance Updates CrossRef - A novel antibody-based approach to detect the functional ERCC1-202 isoform
Mei-Shiue Kuo et al, 2018, DNA Repair CrossRef - Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems
Yi Xiong et al, 2017, Medical Oncology CrossRef - A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis
Yali Han et al, 2016, Disease Markers CrossRef - Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis
Li-Ming Tan et al, 2017, Scientific Reports CrossRef - Molecular Markers for Treatment Response and Toxicity of Gemcitabine
L.V.K.S. Bhaskar et al, 2019, Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy CrossRef - Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer
Shao-jun Huang et al, 2014, Tumor Biology CrossRef - Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1
Gerhard Hamilton et al, 2018, Expert Opinion on Drug Metabolism & Toxicology CrossRef - Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer
Qingxiang Lin et al, 2022, Molecular & Cellular Proteomics CrossRef - Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta‐Analysis
Hilary Sito et al, 2024, British Journal of Biomedical Science CrossRef - Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
Paweł Krawczyk et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef - The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer
Joshua T. Burgess et al, 2020, Frontiers in Oncology CrossRef - Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer
Hilary Sito et al, 2024, Molecular Biology Reports CrossRef